Torrent Pharma launches Adalimumab biosimilar in India - Feedback

Drug firm Torrent Pharmaceuticals has launched in India its biosimilar Adalimumab, used for the treatment of auto immune disorders, under the brand name ^Adfrar^. The company^s product will be available as pre-filled syringe of 40 mg, Torrent Pharmaceuticals said in a statement. It, however, did not give any details about the price at which the biosimilar will be available.

About news

We take care of publishing the latest investment news and highlights for Feedback

Leave a Reply

Your email address will not be published. Required fields are marked *